Representing Kansas bioscience companies and research institutions
Home About KansasBio Membership Center Bioscience News Contact KansasBio
Information Resources Education & Training Networking & Collaboration Business & Investment


Up-to-the minute latest news in the biotechnology sector and from biotech companies in Kansas and around the world

  KansasBio photos  


Biotechnology Headlines from PR Newswire

SQI Diagnostics Reports Fourth Quarter and Fiscal 2014 Results
"Master Regulator" Gene -- Long Tied To Autism Disorders -- Can Stimulate Other Genes Involved In Early Brain Development
Successful FDA Inspection at Hovione
Curemark CEO Delivers Keynote Speech at Epigenetics Conference
First Patient Treated in Mapi Pharma's Phase IIa Clinical Trial of GA Depot for Relapsing Remitting Multiple Sclerosis (RRMS)
BIONOVA asks: Men Skincare is a necessity or a treat?
PAREXEL International Announces Date Of Second Quarter Fiscal Year 2015 Earnings Release And Conference Call
Novogen Raises A$4.1m In Private Placement to US Institutions
Halozyme Therapeutics Enters A Global Collaboration With Janssen To Develop And Commercialize Subcutaneous Products Using ENHANZE™ Technology
Generex Announces Participation in MedCannAccess® - CannScience Partnership on Non-Smoked Forms of Marijuana
Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris
Synageva BioPharma To Present At The 33rd Annual J.P. Morgan Healthcare Conference On Monday, January 12, 2015 at 9:00 a.m. PST
Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus
RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301
IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019
CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma
United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change
First European Approval for Implant Made of PEEK-OPTIMA® HA Enhanced
Cardio3 Biosciences Will be Present at ODDO Midcap Forum
Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board
Dr. Gary Levine, President of National Consortium of Breast Centers, to Lead MemorialCare Health System Breast Centers in Southern California
Remote Medical Technologies Proves That Live, Dynamic, High Definition Tele-Ultrasound Is The Future of Tele-Radiology
Motus Adds Top Orthopedic Surgeon Advisors to Advance Product Development
Micro Market Monitor: Global Biologicals Market
Novogen Announces Breakthrough Discovery in the Treatment of Melanoma
Intersections Inc. (INTX) announces launch of Voyce™
Expanding Orthopedics Closes First US Distribution Agreement for its 3D Expandable FLXfit™ Cage
Portage announces further successful validation of its new proprietory cell permeable peptide platform technology
DIATHERIX Laboratories Receives Second Research Contract from FDA and HHS
Intronix Technologies to Collaborate with Western University to Develop New Rehabilitation Technologies for Musculoskeletal Disorders
SomaGenics Awarded Four Patents Spanning Its miRNA and RNAi Programs
NewGen Therapeutics Targeted Anti-Cancer Drug, NT-113, Demonstrates Compelling Activity in Glioblastoma Xenograft Models
BHI Celebrates Funding Successes of Clients BeneVir BioPharm, Inc. and Perceptive Navigation, LLC
Great Basin Appoints New Board Members
SOV Therapeutics announces Successful Phase IIb Study of Oral Testosterone Undecanoate for Treatment of Primary and Secondary Hypogonadism in Adult Males
Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015
Spark Therapeutics Appoints Rare Disease Pioneer Dr. Rogerio Vivaldi as Chief Commercial Officer
ContraVir Pharmaceuticals Appoints Nathaniel Katz, M.D., Chairman of New Scientific Advisory Board
Renmatix Acquires Sweden-based REAC Fuel's Intellectual Property Spanish
Best Hospitals, Best Cancer Hospitals Rapidly Adopt Surefire Infusion System for Minimally Invasive, Direct-To-Tumor Interventional Procedures
Crescendo Biologics' Receives Further Investment from Astellas Venture Management to Develop Novel Humabody™ Therapeutics Targeting Immune Checkpoint Inhibitors
The Asia-Pacific Isothermal Nucleic Acid Amplification Market is Expected to Grow at a CAGR of 17.1% from 2014 to 2019
A Novel Tool To Study Life-Threatening Arrhythmias: A Genetically Engineered Pig
HITLAB Completes GCP Audit for FDA Smart Device & App Compliance
Ceres Announces Changes to Board of Directors
Valeant Pharmaceuticals To Hold Conference Call To Announce 2015 Financial Guidance
Lilly Announces Dividend Increase
Express Scripts Initiates Chief Financial Officer Transition Process; Increases Authorization of Share Repurchase Program; and Reaffirms 2014 Guidance
PDL BioPharma Completes Regular Quarterly Dividend Payment
Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain

< Prev Next >
PR Newswire - United Business Media

Kansas Bioscience Association

© 2004 Kansas Bioscience Organization (KansasBio). All rights reserved.